Immune Therapeutics Announces Special Investor Conference Call to Discuss 2017 Outlook
27 janv. 2017 15h40 HE
|
Immune Therapeutics, Inc.
ORLANDO, Fla., Jan. 27, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage company developing novel therapies for the treatment of immuno-inflammatory diseases and...
Immune Therapeutics Retains Investor Relations Partners to Support Company’s Strategic IR Program as it Prepares for Commercialziation
26 janv. 2017 10h16 HE
|
Investor Relations Partners
ORLANDO, Fla., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Investor Relations Partners (IRP), one of the fastest growing investor and public relations firms in the nation, today announced that Immune...